SE389331B - Forfarande for framstellning av vissa angivna 2,2-metylendifenoler. - Google Patents

Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.

Info

Publication number
SE389331B
SE389331B SE7204544A SE454472A SE389331B SE 389331 B SE389331 B SE 389331B SE 7204544 A SE7204544 A SE 7204544A SE 454472 A SE454472 A SE 454472A SE 389331 B SE389331 B SE 389331B
Authority
SE
Sweden
Prior art keywords
methylendiphenols
procedure
preparation
certain stated
stated
Prior art date
Application number
SE7204544A
Other languages
English (en)
Swedish (sv)
Inventor
Samuel Van Der Meer
Hendrikus Matheus Van Alphen
Original Assignee
Acf Chemiefarma Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acf Chemiefarma Nv filed Critical Acf Chemiefarma Nv
Publication of SE389331B publication Critical patent/SE389331B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7204544A 1971-04-09 1972-04-07 Forfarande for framstellning av vissa angivna 2,2-metylendifenoler. SE389331B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7104839.A NL167151C (nl) 1971-04-09 1971-04-09 Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen.

Publications (1)

Publication Number Publication Date
SE389331B true SE389331B (sv) 1976-11-01

Family

ID=19812895

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7204544A SE389331B (sv) 1971-04-09 1972-04-07 Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.

Country Status (19)

Country Link
US (1) US3884906A (Direct)
JP (2) JPS5525177B1 (Direct)
AR (2) AR194587A1 (Direct)
AU (1) AU459272B2 (Direct)
BE (1) BE781674A (Direct)
CH (2) CH575372A5 (Direct)
DE (1) DE2215409C3 (Direct)
DK (1) DK143227C (Direct)
ES (1) ES401501A1 (Direct)
FR (1) FR2132788B1 (Direct)
GB (1) GB1346266A (Direct)
HU (1) HU165790B (Direct)
IE (1) IE36209B1 (Direct)
IL (1) IL39108A (Direct)
NL (1) NL167151C (Direct)
PH (2) PH15268A (Direct)
SE (1) SE389331B (Direct)
SU (1) SU580828A3 (Direct)
ZA (1) ZA722331B (Direct)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4101678A (en) * 1977-11-08 1980-05-01 Ici Australia Ltd Process for killing parasites
FR2549476B1 (fr) * 1983-07-20 1986-04-25 Rech Ind Benzyl-phenyl-osides, procede de preparation et utilisation en therapeutique
US6403652B1 (en) 2000-06-30 2002-06-11 Colgate-Palmolive Company Method and composition
IL218714A (en) * 2004-03-16 2013-02-28 Boehringer Ingelheim Int Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
UA91546C2 (uk) * 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
US7772191B2 (en) 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
PE20080697A1 (es) * 2006-05-03 2008-08-05 Boehringer Ingelheim Int Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
CL2008002427A1 (es) * 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
WO2009068617A1 (en) * 2007-11-30 2009-06-04 Boehringer Ingelheim International Gmbh 1, 5-dihydro-pyrazolo (3, 4-d) pyrimidin-4-one derivatives and their use as pde9a modulators for the teatment of cns disorders
UA105362C2 (en) * 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
MX2011002340A (es) 2008-09-08 2011-04-04 Boehringer Ingelheim Int Pirazolopirimidinas y su uso para el tratamiento de trastornos del snc.
JP5685550B2 (ja) 2009-02-13 2015-03-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｓｇｌｔ２阻害剤、ｄｐｐ−ｉｖ阻害剤、更に必要により抗糖尿病薬を含む医薬組成物及びその使用
HRP20240365T1 (hr) * 2009-02-13 2024-06-07 Boehringer Ingelheim International Gmbh Farmaceutski pripravak koji sadrži derivate glukopiranozil difenilmetana, njegov farmaceutski oblik za doziranje, postupak za njihovu proizvodnju i njihove uporabe za poboljšanu regulaciju glikemije kod pacijenta
MX344264B (es) 2009-02-13 2016-12-09 Boehringer Ingelheim Int Gmbh * Inhibidor de sglt-2 para el tratamiento de diabetes mellitus tipo 1, diabetes mellitus tipo 2, tolerancia deteriorada a la glucosa o hiperglucemia.
BRPI1011533A2 (pt) * 2009-03-31 2016-03-29 Boehringer Ingelheim Int derivados de 1-heterocicil-1 5- diidro-pirazolo [3,4--d] pirimidin-4-ona e seu uso como moduladores de pde9a.
TW201118099A (en) * 2009-08-12 2011-06-01 Boehringer Ingelheim Int New compounds for the treatment of CNS disorders
AU2010303123B2 (en) * 2009-09-30 2014-02-27 Boehringer Ingelheim International Gmbh Method for the preparation of a crystalline form of 1-chloro-4- (Beta-D-glucopyranos-1-yl)-2-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)benzene
HUE026133T2 (en) 2009-09-30 2016-05-30 Boehringer Ingelheim Int Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives
UY32919A (es) * 2009-10-02 2011-04-29 Boehringer Ingelheim Int Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos
AP2012006631A0 (en) 2010-08-12 2012-12-31 Boehringer Ingelheim Int 6-Cycloalkyl-1, 5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A inhibitors
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
UY33937A (es) 2011-03-07 2012-09-28 Boehringer Ingelheim Int Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US9192617B2 (en) 2012-03-20 2015-11-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
HK1215398A1 (zh) 2013-04-05 2016-08-26 勃林格殷格翰国际有限公司 依帕列净的治疗用途
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US20140303097A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
CA2812519A1 (en) 2013-04-05 2014-10-05 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
PT2986304T (pt) 2013-04-18 2022-02-25 Boehringer Ingelheim Int Composição farmacêutica, métodos para o tratamento e suas utilizações
MA46742A (fr) 2016-11-10 2019-09-18 Boehringer Ingelheim Int Composition pharmaceutique, méthodes de traitement et leurs utilisations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2544826A (en) * 1945-05-08 1951-03-13 Dow Chemical Co Anthelmintic feed composition
US2615052A (en) * 1950-06-23 1952-10-21 Allied Lab Inc 2,2'-methylenebis(4-chloro-6-nitrophenol) and a method for its production
US2739941A (en) * 1952-09-13 1956-03-27 Gen Aniline & Film Corp Germicidal soap composition
NL283922A (Direct) * 1962-10-03

Also Published As

Publication number Publication date
DK143227B (da) 1981-07-27
PH14191A (en) 1981-03-26
DE2215409C3 (de) 1980-10-09
NL167151C (nl) 1981-11-16
AU4085072A (en) 1973-10-11
AR193590A1 (es) 1973-04-30
SU580828A3 (ru) 1977-11-15
BE781674A (fr) 1972-10-05
AU459272B2 (en) 1975-03-05
ZA722331B (en) 1973-01-31
JPS5525177B1 (Direct) 1980-07-04
NL167151B (nl) 1981-06-16
DE2215409A1 (de) 1973-01-25
DK143227C (da) 1981-11-30
DE2215409B2 (de) 1980-02-14
HU165790B (Direct) 1974-11-28
IL39108A (en) 1976-04-30
NL7104839A (Direct) 1972-10-11
CH575372A5 (Direct) 1976-05-14
IE36209L (en) 1972-10-09
ES401501A1 (es) 1975-02-16
JPS5950645B2 (ja) 1984-12-10
GB1346266A (en) 1974-02-06
FR2132788B1 (Direct) 1976-05-14
IE36209B1 (en) 1976-09-15
AR194587A1 (es) 1973-07-31
PH15268A (en) 1982-11-02
FR2132788A1 (Direct) 1972-11-24
JPS557256A (en) 1980-01-19
IL39108A0 (en) 1972-05-30
CH586182A5 (Direct) 1977-03-31
US3884906A (en) 1975-05-20

Similar Documents

Publication Publication Date Title
SE389331B (sv) Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
FI55186B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara osymmetriska 1,4-dihydropyridinkarboxylsyraestrar
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
BG20336A3 (bg) Метод за получаване на 3-карбомоил-2.4.6- трийдефинил-алкилетери
BG19375A3 (bg) Метод за получаване на 3,4-1н-изохиномин-1-они
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE7505279L (sv) Forfarande for framstellning av hydroxipyrimidiner.
SE406587B (sv) Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin
NO137093C (no) Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner
SE394677B (sv) Forfarande for framstellning av 4-hydroxi-2h-1-bensotiopyran-3-karboxanilid-1,1-dioxider
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
NO136046C (no) Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner.
SE383521B (sv) Forfarande for framstellning av kardenolid-3-(2',3-dedesoxi-2,'3'-oxido-glykosider).
SE400548B (sv) Forfarande for framstellning av en substituerad bensoylester av en 1,8,9-trihydroxiantracen
NO136195C (no) Fremgangsm}te ved fremstilling av 2,4-diamino-5-benzylpyrimidiner.
DK130308B (da) Fremgangsmåde til fremstilling af 13β-alkylgona-4,9,11-triener.
SE401366B (sv) Forfarande for framstellning av 2,6-metano-3-bensazociner
SE389103B (sv) Forfarande for framstellning av 1,4-metano-och 1,4-etanotetrahydro
SE389335B (sv) Forfarande for framstellning av vissa angivna ketaziner.
DK131189B (da) Analogifremgangsmåde til fremstilling af 16-hydroxylerede 17alfa-ethynyl-17beta-hydroxy-13beta-alkylgona-4,9,11-trien-3-oner.
NO138140C (no) Fremgangsmaate for fremstilling av 4,4`-ditert.butyl-benzoylperoksyd
DK134518B (da) Analogifremgangsmåde til fremstilling af 4beta-alkoxy-4alfa-(3'-hydroxyphenyl)-3alfa,5alfa-propanopiperidin-derivater.
NO137940C (no) Analogifremgangsmaate til fremstilling av 4`,5-dinitro-3`-trifluormetyl-2-tiofenanilid